Editorial in the British Medical Journal smashes the serious compromises made by governments in antibody testing kits and #Remdesivir research and grant of permission to sell. 
UK government invoked confidentiality clause to avoid naming nine suppliers of antibody kits that were found inaccurate. US govt also relaxed it’s norms to allow substandard testing kits. Most likely India is also following their footsteps (list of suppliers attached).
The NEJM Remdesivir study -researchers were on Gilead payroll, medicine supplied by Gilead for trials, company involved in clinical protocols, patients swapped from placebo to Remdesivir midway.
